search
Back to results

Self-Care for Dementia Caregivers (Care2)

Primary Purpose

Aging, Mental Disorder, Eating, Healthy

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Behavioral Self-Monitoring + Motivational Interviewing
Enhanced Usual Care
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Aging focused on measuring Caregivers, Carers, Alzheimer Disease, Alzheimer Dementia, Dementia, Twenty-Four Hour Rhythm, Geriatrics, Self Care, Circadian Rhythm

Eligibility Criteria

50 Years - 99 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 50 years old or older
  • family member of the care recipient (spouse, child, or fictive kin)
  • Provides at least 8 hours of care/ week
  • Lives in same household as the care recipient
  • Difficulty engaging in self-care practices including sleep, exercise, and/or social activity with others
  • Mild level of psychological distress (defined by a score > 3 on either the PHQ-2 or GAD-2 and/or score > 48 on the Zarit Burden Interview.)

Exclusion Criteria:

  • Living in a nursing home
  • intent to institutionalize loved one in near future (12 months)
  • Under 50 years of age

Sites / Locations

  • University of PittsburghRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Caregiver Intervention

Enhanced Usual Care

Arm Description

Behavioral self-monitoring of daily physical activity, dietary, and sleep behaviors for 6 weeks, into the myRW app; and behavioral self monitoring + motivational interviewing health coaching.

Participants randomized to this condition will receive the written education provided to all participants, along with weekly check-in calls.

Outcomes

Primary Outcome Measures

Change from baseline in Caregiver Burden throughout research study
The Zarit Burden Interview is a self-reported questionnaire that assesses caregiver burnout. Caregiver Burden will be assessed throughout the study, namely pre- and post-intervention and at 3-month follow-up. A score of 0-10 indicates mild to no burden and a score of 20 or higher indicates a high level of burden, or worse result.

Secondary Outcome Measures

Change from baseline in depressive symptoms throughout research study
The 9-item Patient Health Questionnaire (PHQ-9) scale is a self-reported questionnaire to be completed by the participant that assesses severity of depression. The PHQ-9 will be administered throughout the study to assess changes in depressive symptoms pre- and post-intervention, and at the 3-month follow-up visit. A minimum score on this metric is a 0, indicating no impact to patient health, and ranges up to a maximum score of 27, indicating more severe impacts to patient health.
Change from baseline in anxiety symptoms throughout research study
The 7-item Generalized Anxiety Disorder Scale (GAD-7) will be administered throughout the study to assess changes in anxiety symptoms pre and post-intervention, and at 3-month follow-up visit. The whole scale score can range from 0 to 21, with severity increasing as values increase. The threshold of 5 or higher indicates mild anxiety symptoms, 10 or higher indicates moderate anxiety symptoms, and 15 or higher indicates severe anxiety symptoms.

Full Information

First Posted
March 24, 2022
Last Updated
April 4, 2023
Sponsor
University of Pittsburgh
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05309577
Brief Title
Self-Care for Dementia Caregivers
Acronym
Care2
Official Title
Self-Care for Dementia Caregivers
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 9, 2023 (Actual)
Primary Completion Date
November 30, 2023 (Anticipated)
Study Completion Date
November 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
Collaborators
National Institute on Aging (NIA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The Self-Care for Dementia Caregivers research study is a pilot randomized control trial (RCT) to develop and evaluate the feasibility of a behavioral intervention that uses technology and motivational health coaching to optimize caregivers' sleep, exercise, and social activities. Caregivers of family members with Alzheimer's Disease (AD) and AD-related dementias often experience disruptions of their biological or behavioral time cues, placing them at higher risk for adverse health outcomes. The investigators hypothesize that targeting the stability of sleep, exercise, and social activities will improve stability of the biological clock, improve caregiver health and wellbeing, and improve their ability to provide care.
Detailed Description
Caregivers of family members with Alzheimer's Disease (AD) and AD-related dementias (ADRD) experience high rates of psychological stress, physical impairments, and often, disruptions in normal daily activities. Caregivers must be alert both at night and during the day, and often on an inconsistent schedule. As a result, caregivers are less likely to sleep, exercise, and be socially active on a regular schedule. Disruptions of these biological and behavioral time cues, or "zeitgebers", in turn decrease the stability of the body's biological clock, placing caregivers at high risk for adverse health outcomes related to an out-of-sync biological clock (e.g. diabetes, cardiovascular disease, and depression, among others). Caregivers of individuals with ADRD experience worse health outcomes compared with other types of caregivers, likely due to more heavily or frequently disrupted schedules. For this research study, 25 individuals aged 50 and older who are providing care for a family member with mild-to-moderate dementia. Data from 5 participants will be used for the development of an intervention manual (NIH Stage Model IA). A small pilot study will be conducted (NIH Stage Model IB) in which 20 participants will be randomly assigned to 6 weeks of the caregiver intervention or enhanced usual care arm. Objective actigraphic measures of the 24-hour pattern of sleep and daytime activity - known as the rest-activity rhythm (RAR) - will be measured for 7 days at the start and end of the assigned intervention procedures to evaluate circadian rhythms as a potential intervention target/mechanism of action. The investigators will measure the regularity, timing, and amplitude of behavioral patterns over a 24-hour period. Participants will be assessed at baseline, post-intervention, and 3-months post-intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aging, Mental Disorder, Eating, Healthy, Physical Inactivity, Prodromal Symptoms, Sleep, Alzheimer Disease, Dementia, Circadian Rhythm Disorders
Keywords
Caregivers, Carers, Alzheimer Disease, Alzheimer Dementia, Dementia, Twenty-Four Hour Rhythm, Geriatrics, Self Care, Circadian Rhythm

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
25 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Caregiver Intervention
Arm Type
Active Comparator
Arm Description
Behavioral self-monitoring of daily physical activity, dietary, and sleep behaviors for 6 weeks, into the myRW app; and behavioral self monitoring + motivational interviewing health coaching.
Arm Title
Enhanced Usual Care
Arm Type
Active Comparator
Arm Description
Participants randomized to this condition will receive the written education provided to all participants, along with weekly check-in calls.
Intervention Type
Behavioral
Intervention Name(s)
Behavioral Self-Monitoring + Motivational Interviewing
Intervention Description
Participants randomized to the self-monitoring arm (n=10) will record the timing of sleep, social activities and exercise twice daily using a diary-like Qualtrics website, for 6 weeks. The steps of behavioral self-monitoring include: (1) selecting a goal, (2) paying attention to some aspect of behavior, and (3) recording some details of that behavior in a daily diary. Participants will also interact with a 'health coach' about their recorded behaviors weekly. This health coach will use motivational interviewing to enhance older adult caregivers' confidence and intrinsic motivation to engage in regular self-care.
Intervention Type
Behavioral
Intervention Name(s)
Enhanced Usual Care
Intervention Description
In the enhanced usual care group (n=10), participants will be provided with the same educational information as the caregiver intervention arm, but without the tailored advice, motivational health coaching, or digital feedback (e.g. Qualtrics website/daily diary; lifestyle log) that participants in the caregiver intervention arm will receive. Enhanced usual care participants will have the same assessment schedule as caregiver intervention participants. They will also receive weekly calls from a staff member.
Primary Outcome Measure Information:
Title
Change from baseline in Caregiver Burden throughout research study
Description
The Zarit Burden Interview is a self-reported questionnaire that assesses caregiver burnout. Caregiver Burden will be assessed throughout the study, namely pre- and post-intervention and at 3-month follow-up. A score of 0-10 indicates mild to no burden and a score of 20 or higher indicates a high level of burden, or worse result.
Time Frame
Up to 4.5 months
Secondary Outcome Measure Information:
Title
Change from baseline in depressive symptoms throughout research study
Description
The 9-item Patient Health Questionnaire (PHQ-9) scale is a self-reported questionnaire to be completed by the participant that assesses severity of depression. The PHQ-9 will be administered throughout the study to assess changes in depressive symptoms pre- and post-intervention, and at the 3-month follow-up visit. A minimum score on this metric is a 0, indicating no impact to patient health, and ranges up to a maximum score of 27, indicating more severe impacts to patient health.
Time Frame
Up to 4.5 months
Title
Change from baseline in anxiety symptoms throughout research study
Description
The 7-item Generalized Anxiety Disorder Scale (GAD-7) will be administered throughout the study to assess changes in anxiety symptoms pre and post-intervention, and at 3-month follow-up visit. The whole scale score can range from 0 to 21, with severity increasing as values increase. The threshold of 5 or higher indicates mild anxiety symptoms, 10 or higher indicates moderate anxiety symptoms, and 15 or higher indicates severe anxiety symptoms.
Time Frame
Up to 4.5 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 50 years old or older family member of the care recipient (spouse, child, or fictive kin) Provides at least 8 hours of care/ week Lives in same household as the care recipient Difficulty engaging in self-care practices including sleep, exercise, and/or social activity with others Mild level of psychological distress (defined by a score > 3 on either the PHQ-2 or GAD-2 and/or score > 48 on the Zarit Burden Interview.) Exclusion Criteria: Living in a nursing home intent to institutionalize loved one in near future (12 months) Under 50 years of age
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Emilee Croswell, BS
Phone
412-440-8418
Email
croswellej@upmc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sarah T Stahl, PhD
Organizational Affiliation
University of Pittsburgh, Assistant Professor of Psychiatry and Clinical and Translational Science
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15260
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emilee Croswell, BS
Phone
412-440-8418
Email
Croswellej@upmc.edu
First Name & Middle Initial & Last Name & Degree
Sarah T Stahl, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All individual participant data collected during the trial will be available, after de-identification.
IPD Sharing Time Frame
Immediately following publication. No end date.
IPD Sharing Access Criteria
De-identified individual participant date will be available indefinitely following publication. It may be shared with researchers who provide a methodologically sound proposal for the purpose of achieving the aims in the approved proposal. Proposals should be directed to sts80@pitt.edu. Approved requestors will need to sign a data access management agreement.

Learn more about this trial

Self-Care for Dementia Caregivers

We'll reach out to this number within 24 hrs